200 related articles for article (PubMed ID: 6982592)
1. Target antigens for bactericidal and opsonizing antibodies to Haemophilus influenzae.
Dahlberg-Lagergård T
Acta Pathol Microbiol Immunol Scand C; 1982 Aug; 90(4):209-16. PubMed ID: 6982592
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal antibodies against noncapsular components of Haemophilus influenzae.
Dahlberg-Lagergård T
J Clin Microbiol; 1983 Mar; 17(3):428-31. PubMed ID: 6601665
[TBL] [Abstract][Full Text] [Related]
3. Further studies of the role of noncapsular antibody in protection against experimental Haemophilus influenzae type b bacteremia.
Shenep JL; Munson RS; Barenkamp SJ; Granoff DM
Infect Immun; 1983 Oct; 42(1):257-63. PubMed ID: 6604698
[TBL] [Abstract][Full Text] [Related]
4. Characterization of antigens from nontypable Haemophilus influenzae recognized by human bactericidal antibodies. Role of Haemophilus outer membrane proteins.
Gnehm HE; Pelton SI; Gulati S; Rice PA
J Clin Invest; 1985 May; 75(5):1645-58. PubMed ID: 3873475
[TBL] [Abstract][Full Text] [Related]
5. Antibody responses to capsular polysaccharide, lipopolysaccharide, and outer membrane in adults infected with Haemophilus influenzae type b.
Lagergård T; Nylén O; Sandberg T; Trollfors B
J Clin Microbiol; 1984 Dec; 20(6):1154-8. PubMed ID: 6335151
[TBL] [Abstract][Full Text] [Related]
6. Human bactericidal antibody response to outer membrane protein P2 of nontypeable Haemophilus influenzae.
Murphy TF; Bartos LC
Infect Immun; 1988 Oct; 56(10):2673-9. PubMed ID: 2843467
[TBL] [Abstract][Full Text] [Related]
7. Human serum activities against Hemophilus influenzae, type b.
Anderson P; Johnston RB; Smith DH
J Clin Invest; 1972 Jan; 51(1):31-8. PubMed ID: 4536614
[TBL] [Abstract][Full Text] [Related]
8. Immunity to Haemophilus influenzae type b in young adults: correlation of bactericidal and opsonizing activity of serum with antibody to polyribosylribitol phosphate and lipooligosaccharide before and after vaccination.
Musher D; Goree A; Murphy T; Chapman A; Zahradnik J; Apicella M; Baughn R
J Infect Dis; 1986 Dec; 154(6):935-43. PubMed ID: 3491165
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of phenotypic variants of Haemophilus influenzae type b to serum bactericidal activity: relation to surface lipopolysaccharide.
Gilsdorf JR; Ferrieri P
J Infect Dis; 1986 Feb; 153(2):223-31. PubMed ID: 3484771
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies to Haemophilus influenzae type b.
Amir J; Scott MG; Nahm MH; Granoff DM
J Infect Dis; 1990 Jul; 162(1):163-71. PubMed ID: 2355193
[TBL] [Abstract][Full Text] [Related]
11. Antibody response of infants to cell surface-exposed outer membrane proteins of Haemophilus influenzae type b after systemic Haemophilus disease.
Gulig PA; McCracken GH; Frisch CF; Johnston KH; Hansen EJ
Infect Immun; 1982 Jul; 37(1):82-8. PubMed ID: 6980838
[TBL] [Abstract][Full Text] [Related]
12. Development of a serological assay to predict antibody bactericidal activity against non-typeable Haemophilus influenzae.
Ercoli G; Baddal B; Alessandra G; Marchi S; Petracca R; Aricò B; Pizza M; Soriani M; Rossi-Paccani S
BMC Microbiol; 2015 Apr; 15():87. PubMed ID: 25927946
[TBL] [Abstract][Full Text] [Related]
13. Protection of infant rats from Haemophilus influenzae type b infection by antiserum to purified outer membrane protein a.
Loeb MR
Infect Immun; 1987 Nov; 55(11):2612-8. PubMed ID: 3499397
[TBL] [Abstract][Full Text] [Related]
14. Fine mapping of outer membrane protein P2 antigenic sites which vary during persistent infection by Haemophilus influenzae.
Duim B; Vogel L; Puijk W; Jansen HM; Meloen RH; Dankert J; van Alphen L
Infect Immun; 1996 Nov; 64(11):4673-9. PubMed ID: 8890224
[TBL] [Abstract][Full Text] [Related]
15. Vaccination of 18-month-old children with conjugated polyribosyl ribitol phosphate stimulates production of functional antibody to Haemophilus influenzae type b.
Musher DM; Watson DA; Lepow ML; McVerry P; Hamill R; Baughn RE
Pediatr Infect Dis J; 1988 Mar; 7(3):156-9. PubMed ID: 3258660
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of Nontypeable Haemophilus influenzae Outer Membrane Vesicles and Protective Ability in the Chinchilla Model of Otitis Media.
Winter LE; Barenkamp SJ
Clin Vaccine Immunol; 2017 Oct; 24(10):. PubMed ID: 28768669
[TBL] [Abstract][Full Text] [Related]
17. Role of lipopolysaccharide phase variation in susceptibility of Haemophilus influenzae to bactericidal immunoglobulin M antibodies in rabbit sera.
Erwin AL; Brewah YA; Couchenour DA; Barren PR; Burke SJ; Choi GH; Lathigra R; Hanson MS; Weiser JN
Infect Immun; 2000 May; 68(5):2804-7. PubMed ID: 10768976
[TBL] [Abstract][Full Text] [Related]
18. Naturally occurring bactericidal antibodies specific for Haemophilus influenzae lipooligosaccharide are present in healthy adult individuals.
Choi J; Nix EB; Gaultier GN; Cox AD; McCready W; Ulanova M
Vaccine; 2015 Apr; 33(16):1941-7. PubMed ID: 25738817
[TBL] [Abstract][Full Text] [Related]
19. Serum bactericidal effect on capsulated and non-capsulated Haemophilus influenzae in chronic sinusitis.
Harada T; Sakakura Y; Miyoshi Y
Arch Otorhinolaryngol; 1984; 240(1):79-83. PubMed ID: 6610409
[TBL] [Abstract][Full Text] [Related]
20. Effect of lipid modification on the physicochemical, structural, antigenic and immunoprotective properties of Haemophilus influenzae outer membrane protein P6.
Yang YP; Munson RS; Grass S; Chong P; Harkness RE; Gisonni L; James O; Kwok Y; Klein MH
Vaccine; 1997 Jun; 15(9):976-87. PubMed ID: 9261944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
